tak 044 has been researched along with Cardiovascular Stroke in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awane, Y; Fujino, M; Fujiwara, S; Ikeda, S; Kikuchi, T; Kubo, K; Kusumoto, K; Wakimasu, M; Watanabe, T | 1 |
| Fujino, M; Fujiwara, S; Kojima, M; Kusumoto, K; Watanabe, T | 1 |
| Fukuchi, M; Kagaya, Y; Kohzuki, M; Namiuchi, S; Ninomiya, M; Otani, H; Shirato, K; Takahashi, C; Takeda, M; Watanabe, J; Yamane, Y | 1 |
3 other study(ies) available for tak 044 and Cardiovascular Stroke
| Article | Year |
|---|---|
Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats.
Topics: Animals; Blood Pressure; Brain; Coronary Vessels; Endothelin Receptor Antagonists; Endothelium, Vascular; In Vitro Techniques; Iodine Radioisotopes; Male; Membranes; Muscle, Smooth, Vascular; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Peptides, Cyclic; Rabbits; Rats; Rats, Wistar; Swine | 1995 |
Role of endogenous endothelin in the extension of myocardial infarct size studied with the endothelin receptor antagonist, TAK-044.
Topics: Animals; Dogs; Endothelin Receptor Antagonists; Endothelins; Glyburide; Male; Myocardial Infarction; Peptides, Cyclic; Rabbits; Rats; Rats, Wistar; Receptors, Purinergic P1; Xanthines | 1995 |
Nonselective endothelin receptor antagonist initiated soon after the onset of myocardial infarction may deteriorate 24-hour survival.
Topics: Animals; Blood Pressure; Endothelin Receptor Antagonists; Endothelin-1; Male; Myocardial Infarction; Peptides, Cyclic; Rats; Rats, Wistar; Receptors, Endothelin; Ventricular Remodeling | 2001 |